Alkem Laboratories opened at ₹5,206.00, in line with its previous close of ₹5,205.00. During today's session, the stock has traded between ₹5,172.00 and ₹5,288.50, with an average traded price of ₹5,238.21. It is currently showing an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Alkem Laboratories is now worth
₹ 13,325.00
giving a profit of
₹ 3,325.00 (33.25%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+45.00 (+0.86%)
Day High
₹5,288.50
Day Low
₹5,172.00
Day Open
₹5,206.00
Prev Close
₹5,205.00
Volume
1,03,084
Value Traded
₹54.00 Cr
1W Return
1.11%
1M Return
3.19%
3M Return
-7.40%
6M Return
-3.49%
1Y Return
-3.75%
Market Cap (₹ Cr.)
62,772
PE Ratio
28.30
PB Ratio
4.52
Dividend Yield
1.02%
ROE
16.40%
ROCE
18.84%
Book Value (₹)
1,155.87
Face Value (₹)
2.00
EPS (TTM)
43.49
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
1.11%
6 Week
-
1 Month
3.19%
3 Month
-7.40%
9 Month
-10.52%
Alkem Laboratories appoints Tiwari and Vartak to senior management roles
Alkem Laboratories appointed Laxmikant Tiwari and Niles Vartak to senior management positions on October 12, 2026. Tiwari brings 27+ years of experience in pharmaceutical operations with an MBA in Operations Management. Vartak has 24+ years of experience in supply chain leadership across pharma and consumer goods sectors. Appointments are effective for the duration of their respective employments with the company.
YesterdayAlkem Labs shares worth ₹26.69 crore change hands in large trade
Large-trade signal flagged for Alkem Laboratories on NSE. Approximately 50,611 shares changed hands at ₹5,274.00. Combined value of the flagged activity stood at ₹26.69 crore.
YesterdayAlkem Laboratories CFO Nitin Agrawal resigns effective Sep 30, 2026
Alkem Laboratories CFO Nitin Agrawal resigned to pursue new opportunities. Cessation from Senior Management Personnel role effective September 30, 2026. Resignation letter dated July 30, 2026, cited personal growth alignment. Agrawal oversaw key acquisitions including Adroit, Bombay Ortho, and Occlutech.
19 days agoAlkem Laboratories to meet HDFC Mutual Fund on Oct 7
Alkem Laboratories scheduled an in-person meeting with HDFC Mutual Fund for October 7, 2026. The interaction is designated as a one-on-one meet in Mumbai. Disclosure made to BSE and NSE under SEBI (LODR) Regulations, 2015. Meeting schedule subject to change based on investor or company exigencies.
20 days agoAlkem launches NeuCeno (cenobamate) for partial-onset seizures in India
Alkem launches NeuCeno (cenobamate) on September 16, 2026, for partial-onset seizures in adults. Cenobamate is launched for the first time in India, offering a once daily oral therapy. Clinical studies show up to 78% reduction in seizure frequency with adjunctive use. Available in six tablet strengths ranging from 12.5 mg to 200 mg. Targets India's estimated 9.4 million epilepsy patients with uncontrolled seizures.
27 days agoAlkem Laboratories launches Renocia Exo hair growth serum
Alkem Laboratories launched Renocia Exo on September 8, 2026. Product is India’s first patented Ginsenoside Exosome-based serum. Formulation targets follicular health via biomimetic peptides. Aims to address hair loss driven by lifestyle and genetics.
1mo ago| Contract | Days to Expiry | LTP | Change | Change % | Volume | OI | OI Chg % |
|---|---|---|---|---|---|---|---|
| ALKEM OCT FUT | 15 | 5,289.00 | 55.50 | 1.06 | 85,750 | 16,30,875 | 0.45 |
| ALKEM NOV FUT | 42 | 5,319.00 | 68.00 | 1.30 | 2,125 | 12,625 | 1.00 |
| ALKEM DEC FUT | 78 | 5,300.00 | 0.00 | 0.00 | 0 | 875 | 0.00 |
| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹351.00 | +1.34% | ₹57,202.26 | 134.86 | -0.69% |
An investment of ₹10,000 made 5 years ago in Alkem Laboratories is now worth
₹ 13,325.00
giving a profit of
₹ 3,325.00 (33.25%)
Note: Past profits do not guarantee future returns.
